RNA Working Capital Ratio

Atrium Therapeutics Inc · Working Capital Ratio

RNA logo

RNA Working Capital Ratio

Latest reported83.00%
RNA FY Working Capital Ratio (83.00% → 83.00%)
More history is needed to export this chart.

RNA working capital ratio history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Atrium Therapeutics Inc Working Capital Ratio — Annual fiscal periods
Period endingWorking Capital Ratio
83.004%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.